Darin Nelson - Publications

Optical Imaging, New York, NY, United States 

56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Nelson DR, Peter J. Hepatitis C virus: how to provide the best treatment with what I have. Liver International : Official Journal of the International Association For the Study of the Liver. 36: 58-61. PMID 26725898 DOI: 10.1111/liv.13004  0.48
2015 Bae JP, Lage MJ, Mo D, Nelson DR, Hoogwerf BJ. Obesity and Glycemic Control in Patients With Diabetes Mellitus: Analysis of Physician Electronic Health Records in the US From 2009-2011. Journal of Diabetes and Its Complications. PMID 26689451 DOI: 10.1016/j.jdiacomp.2015.11.016  0.48
2015 Svarovskaia ES, Gane E, Dvory-Sobol H, Martin R, Doehle B, Hedskog C, Jacobson IM, Nelson DR, Lawitz E, Brainard DM, McHutchison JG, Miller MD, Mo H. L159F and V321A Sofosbuvir Resistance Associated HCV NS5B Substitutions. The Journal of Infectious Diseases. PMID 26603202 DOI: 10.1093/infdis/jiv564  0.48
2015 Brown RS, O'Leary JG, Reddy KR, Kuo A, Morelli GJ, Burton JR, Stravitz RT, Durand C, Di Bisceglie AM, Kwo P, Frenette CT, Stewart TG, Nelson DR, Fried MW, Terrault NA, et al. Interferon-free Therapy for Genotype 1 Hepatitis C in Liver Transplant Recipients: Real World Experience from HCV-TARGET. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 26519873 DOI: 10.1002/lt.24366  0.48
2015 Reau N, Fried MW, Nelson DR, Brown RS, Everson GT, Gordon SC, Jacobson IM, Lim JK, Pockros PJ, Reddy KR, Sherman KE. HCV Council - Critical Appraisal of Data: Recommendations for Clinical Practice in a Rapidly Evolving Therapeutic Landscape. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26509462 DOI: 10.1111/liv.12993  0.48
2015 Sulkowski MS, Vargas HE, Di Bisceglie AM, Kuo PA, Reddy KR, Lim JK, Morelli G, Darling JM, Feld JJ, Brown RS, Frazier LM, Stewart TG, Fried MW, Nelson DR, Jacobson IM, et al. Effectiveness of Simeprevir plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection. Gastroenterology. PMID 26497081 DOI: 10.1053/j.gastro.2015.10.013  0.48
2015 Nelson DB, Hanlon AL, Wu G, Liu C, Fredricks DN. First Trimester Levels of BV-Associated Bacteria and Risk of Miscarriage Among Women Early in Pregnancy. Maternal and Child Health Journal. PMID 26156825 DOI: 10.1007/s10995-015-1790-2  0.48
2015 Kües U, Nelson DR, Liu C, Yu GJ, Zhang J, Li J, Wang XC, Sun H. Genome analysis of medicinal Ganoderma spp. with plant-pathogenic and saprotrophic life-styles. Phytochemistry. 114: 18-37. PMID 25682509 DOI: 10.1016/j.phytochem.2014.11.019  0.48
2015 Nelson DR, Cooper JN, Lalezari JP, Lawitz E, Pockros PJ, Gitlin N, Freilich BF, Younes ZH, Harlan W, Ghalib R, Oguchi G, Thuluvath PJ, Ortiz-Lasanta G, Rabinovitz M, Bernstein D, et al. All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study. Hepatology (Baltimore, Md.). 61: 1127-35. PMID 25614962 DOI: 10.1002/hep.27726  0.48
2015 Peter J, Nelson DR. Optimal interferon-free therapy in treatment-experienced chronic hepatitis C patients. Liver International : Official Journal of the International Association For the Study of the Liver. 35: 65-70. PMID 25529089 DOI: 10.1111/liv.12718  0.48
2015 Afdhal NH, Bacon BR, Patel K, Lawitz EJ, Gordon SC, Nelson DR, Challies TL, Nasser I, Garg J, Wei LJ, McHutchison JG. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 13: 772-9.e1-3. PMID 25528010 DOI: 10.1016/j.cgh.2014.12.014  0.48
2015 Gordon SC, Muir AJ, Lim JK, Pearlman B, Argo CK, Ramani A, Maliakkal B, Alam I, Stewart TG, Vainorius M, Peter J, Nelson DR, Fried MW, Reddy KR. Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET. Journal of Hepatology. 62: 286-93. PMID 25218788 DOI: 10.1016/j.jhep.2014.08.052  0.48
2015 Flamm SL, Muir AJ, Fried MW, Reddy KR, Nelson DR, Bzowej NH, Sullivan JC, Bengtsson L, DeMasi R, Wright CI, Kieffer TL, George S, Adda N, Dusheiko GM. Sustained virologic response rates with telaprevir-based therapy in treatment-naive patients evaluated by race or ethnicity. Journal of Clinical Gastroenterology. 49: 336-44. PMID 24828357 DOI: 10.1097/MCG.0000000000000150  0.48
2015 Chen H, Wu B, Nelson DR, Wu K, Liu C. Correction: Computational Identification and systematic classification of novel cytochrome P450 genes in salvia miltiorrhiza Plos One. 10. DOI: 10.1371/journal.pone.0120063  0.48
2015 Nelson DB, Hanlon AL, Wu G, Liu C, Fredricks DN. First Trimester Levels of BV-Associated Bacteria and Risk of Miscarriage Among Women Early in Pregnancy Maternal and Child Health Journal. DOI: 10.1007/s10995-015-1790-2  0.48
2014 Chen H, Wu B, Nelson DR, Wu K, Liu C. Computational Identification and Systematic Classification of Novel Cytochrome P450 Genes in Salvia miltiorrhiza. Plos One. 9: e115149. PMID 25493946 DOI: 10.1371/journal.pone.0115149  0.48
2014 Svarovskaia ES, Dvory-Sobol H, Parkin N, Hebner C, Gontcharova V, Martin R, Ouyang W, Han B, Xu S, Ku K, Chiu S, Gane E, Jacobson IM, Nelson DR, Lawitz E, et al. Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 1666-74. PMID 25266287 DOI: 10.1093/cid/ciu697  0.48
2014 Di Bisceglie AM, Sulkowski M, Gane E, Jacobson IM, Nelson D, DeSouza C, Alves K, George S, Kieffer T, Zhang EZ, Kauffman R, Asmal M, Koziel MJ. VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection. European Journal of Gastroenterology & Hepatology. 26: 761-73. PMID 24901821 DOI: 10.1097/MEG.0000000000000084  0.48
2014 Sulkowski MS, Jacobson IM, Nelson DR. Daclatasvir plus sofosbuvir for HCV infection. The New England Journal of Medicine. 370: 1560-1. PMID 24738674 DOI: 10.1056/NEJMc1401726  0.48
2014 Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, Nahass R, Ghalib R, Gitlin N, Herring R, Lalezari J, Younes ZH, Pockros PJ, Di Bisceglie AM, Arora S, et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. The New England Journal of Medicine. 370: 1483-93. PMID 24725238 DOI: 10.1056/NEJMoa1316366  0.48
2014 Feld JJ, Kowdley KV, Coakley E, Sigal S, Nelson DR, Crawford D, Weiland O, Aguilar H, Xiong J, Pilot-Matias T, DaSilva-Tillmann B, Larsen L, Podsadecki T, Bernstein B. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. The New England Journal of Medicine. 370: 1594-603. PMID 24720703 DOI: 10.1056/NEJMoa1315722  0.48
2014 Younossi ZM, Stepanova M, Nader F, Jacobson IM, Gane E, Nelson D, Lawitz E, Hunt SL. Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens. Hepatology (Baltimore, Md.). 59: 2161-9. PMID 24710669 DOI: 10.1002/hep.27161  0.48
2014 Fitian AI, Nelson DR, Liu C, Xu Y, Ararat M, Cabrera R. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS. Liver International : Official Journal of the International Association For the Study of the Liver. 34: 1428-44. PMID 24661807 DOI: 10.1111/liv.12541  0.48
2014 Weitzel KW, Elsey AR, Langaee TY, Burkley B, Nessl DR, Obeng AO, Staley BJ, Dong HJ, Allan RW, Liu JF, Cooper-Dehoff RM, Anderson RD, Conlon M, Clare-Salzler MJ, Nelson DR, et al. Clinical pharmacogenetics implementation: approaches, successes, and challenges. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 166: 56-67. PMID 24616371 DOI: 10.1002/ajmg.c.31390  0.48
2014 Nelson D, Yoshida EM, Paulson MS, Hengen PN, Ge D, Kanwar B, McNally J, Pang PS, Subramanian GM, McHutchison JG, Urbanek P, Lawitz E, Urban TJ. Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor. Antiviral Therapy. 19: 679-86. PMID 24503447 DOI: 10.3851/IMP2747  0.48
2014 Kowdley KV, Lawitz E, Poordad F, Cohen DE, Nelson DR, Zeuzem S, Everson GT, Kwo P, Foster GR, Sulkowski MS, Xie W, Pilot-Matias T, Liossis G, Larsen L, Khatri A, et al. Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1. The New England Journal of Medicine. 370: 222-32. PMID 24428468 DOI: 10.1056/NEJMoa1306227  0.48
2014 Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, Lawitz E, Lok AS, Hinestrosa F, Thuluvath PJ, Schwartz H, Nelson DR, Everson GT, Eley T, Wind-Rotolo M, et al. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. The New England Journal of Medicine. 370: 211-21. PMID 24428467 DOI: 10.1056/NEJMoa1306218  0.48
2014 Nelson DB, Hanlon A, Nachamkin I, Haggerty C, Mastrogiannis DS, Liu C, Fredricks DN. Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery. Paediatric and Perinatal Epidemiology. 28: 88-96. PMID 24405280 DOI: 10.1111/ppe.12106  0.48
2014 Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, Nelson D, Nader F, Hunt S. Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C). Journal of Hepatology. 60: 741-7. PMID 24333184 DOI: 10.1016/j.jhep.2013.12.006  0.48
2014 Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, Nelson D, Gerber L, Nader F, Hunt S. Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 12: 1349-59.e13. PMID 24316172 DOI: 10.1016/j.cgh.2013.11.032  0.48
2014 Burgansky-Eliash Z, Barash H, Nelson D, Grinvald A, Sorkin A, Loewenstein A, Barak A. Retinal blood flow velocity in patients with age-related macular degeneration. Current Eye Research. 39: 304-11. PMID 24147793 DOI: 10.3109/02713683.2013.840384  1
2014 Muir AJ, Gong L, Johnson SG, Lee MT, Williams MS, Klein TE, Caudle KE, Nelson DR. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimens. Clinical Pharmacology and Therapeutics. 95: 141-6. PMID 24096968 DOI: 10.1038/clpt.2013.203  0.48
2014 Schmidt WN, Nelson DR, Pawlotsky JM, Sherman KE, Thomas DL, Chung RT. Direct-acting antiviral agents and the path to interferon independence. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 12: 728-37. PMID 23872239 DOI: 10.1016/j.cgh.2013.06.024  0.48
2013 Nelson DB, Komaroff E, Nachamkin I, Haggerty CL, Dibble L, Mastrogiannis D, Liu C, Fredricks DN, David FN. Relationship of selected bacterial vaginosis-associated bacteria to Nugent score bacterial vaginosis among urban women early in pregnancy. Sexually Transmitted Diseases. 40: 721-3. PMID 23945426 DOI: 10.1097/OLQ.0000000000000001  0.48
2013 Poordad F, Lawitz E, Reddy KR, Afdhal NH, Hézode C, Zeuzem S, Lee SS, Calleja JL, Brown RS, Craxi A, Wedemeyer H, Nyberg L, Nelson DR, Rossaro L, Balart L, et al. Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial. Gastroenterology. 145: 1035-1044.e5. PMID 23924660 DOI: 10.1053/j.gastro.2013.07.051  0.48
2013 Kirst ME, Li EC, Wang CX, Dong HJ, Liu C, Fried MW, Nelson DR, Wang GP. Deep sequencing analysis of HCV NS3 resistance-associated variants and mutation linkage in liver transplant recipients. Plos One. 8: e69698. PMID 23922778 DOI: 10.1371/journal.pone.0069698  0.48
2013 Langley RJ, Tsalik EL, van Velkinburgh JC, Glickman SW, Rice BJ, Wang C, Chen B, Carin L, Suarez A, Mohney RP, Freeman DH, Wang M, You J, Wulff J, Thompson JW, ... ... Nelson DR, et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Science Translational Medicine. 5: 195ra95. PMID 23884467 DOI: 10.1126/scitranslmed.3005893  0.48
2013 Chen L, Nelson DR, Zhao Y, Cui Z, Johnston JA. Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States. Bmc Geriatrics. 13: 74. PMID 23865675 DOI: 10.1186/1471-2318-13-74  0.48
2013 Johnson JA, Elsey AR, Clare-Salzler MJ, Nessl D, Conlon M, Nelson DR. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics. Pharmacogenomics. 14: 723-6. PMID 23651020 DOI: 10.2217/pgs.13.59  0.48
2013 Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez-Torres M, Sulkowski MS, Shiffman ML, Lawitz E, Everson G, Bennett M, Schiff E, Al-Assi MT, Subramanian GM, An D, Lin M, ... ... Nelson DR, et al. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. The New England Journal of Medicine. 368: 1867-77. PMID 23607593 DOI: 10.1056/NEJMoa1214854  0.48
2013 Cao M, George TJ, Prima V, Nelson D, Svetlov S. Argininosuccinate synthase as a novel biomarker for inflammatory conditions. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 18: 242-9. PMID 23510167 DOI: 10.3109/1354750X.2013.773080  0.48
2013 Kowdley KV, Lawitz E, Crespo I, Hassanein T, Davis MN, DeMicco M, Bernstein DE, Afdhal N, Vierling JM, Gordon SC, Anderson JK, Hyland RH, Dvory-Sobol H, An D, Hindes RG, ... ... Nelson DR, et al. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial. Lancet (London, England). 381: 2100-7. PMID 23499440 DOI: 10.1016/S0140-6736(13)60247-0  0.48
2013 Lawitz E, Lalezari JP, Hassanein T, Kowdley KV, Poordad FF, Sheikh AM, Afdhal NH, Bernstein DE, Dejesus E, Freilich B, Nelson DR, Dieterich DT, Jacobson IM, Jensen D, Abrams GA, et al. Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. The Lancet. Infectious Diseases. 13: 401-8. PMID 23499158 DOI: 10.1016/S1473-3099(13)70033-1  0.48
2013 Burgansky-Eliash Z, Lowenstein A, Neuderfer M, Kesler A, Barash H, Nelson DA, Grinvald A, Barak A. The correlation between retinal blood flow velocity measured by the retinal function imager and various physiological parameters. Ophthalmic Surgery, Lasers & Imaging Retina. 44: 51-8. PMID 23418734 DOI: 10.3928/23258160-20121221-13  1
2012 Barak A, Burgansky-Eliash Z, Barash H, Nelson DA, Grinvald A, Loewenstein A. The effect of intravitreal bevacizumab (Avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization. European Journal of Ophthalmology. 22: 423-30. PMID 22081670 DOI: 10.5301/ejo.5000074  1
2012 Burgansky-Eliash Z, Barak A, Barash H, Nelson DA, Pupko O, Lowenstein A, Grinvald A, Rubinstein A. Increased retinal blood flow velocity in patients with early diabetes mellitus. Retina (Philadelphia, Pa.). 32: 112-9. PMID 21878846 DOI: 10.1097/IAE.0b013e31821ba2c4  1
2011 Nelson DA, Burgansky-Eliash Z, Barash H, Loewenstein A, Barak A, Bartov E, Rock T, Grinvald A. High-resolution wide-field imaging of perfused capillaries without the use of contrast agent. Clinical Ophthalmology (Auckland, N.Z.). 5: 1095-106. PMID 21887088 DOI: 10.2147/OPTH.S20103  1
2010 Burgansky-Eliash Z, Nelson DA, Bar-Tal OP, Lowenstein A, Grinvald A, Barak A. Reduced retinal blood flow velocity in diabetic retinopathy. Retina (Philadelphia, Pa.). 30: 765-73. PMID 20061994 DOI: 10.1097/IAE.0b013e3181c596c6  1
2009 Izhaky D, Nelson DA, Burgansky-Eliash Z, Grinvald A. Functional imaging using the retinal function imager: direct imaging of blood velocity, achieving fluorescein angiography-like images without any contrast agent, qualitative oximetry, and functional metabolic signals. Japanese Journal of Ophthalmology. 53: 345-51. PMID 19763751 DOI: 10.1007/s10384-009-0689-0  1
2005 Nelson DA, Krupsky S, Pollack A, Aloni E, Belkin M, Vanzetta I, Rosner M, Grinvald A. Special report: Noninvasive multi-parameter functional optical imaging of the eye. Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society For Imaging in the Eye. 36: 57-66. PMID 15688972  1
2004 Grinvald A, Bonhoeffer T, Vanzetta I, Pollack A, Aloni E, Ofri R, Nelson D. High-resolution functional optical imaging: from the neocortex to the eye. Ophthalmology Clinics of North America. 17: 53-67. PMID 15102513 DOI: 10.1016/j.ohc.2003.12.003  1
1997 Roerig B, Nelson DA, Katz LC. Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 8353-62. PMID 9334409  1
1995 Yuste R, Nelson DA, Rubin WW, Katz LC. Neuronal domains in developing neocortex: mechanisms of coactivation. Neuron. 14: 7-17. PMID 7826643 DOI: 10.1016/0896-6273(95)90236-8  1
1995 Nelson DA, Katz LC. Emergence of functional circuits in ferret visual cortex visualized by optical imaging. Neuron. 15: 23-34. PMID 7619527 DOI: 10.1016/0896-6273(95)90061-6  1
1993 Nelson DA. Tourette's and stress. Neurology. 43: 237-9. PMID 8423905  1
1989 Nelson DA. Dangers of lumbar spinal needle placement. Annals of Neurology. 25: 310. PMID 2729919 DOI: 10.1002/ana.410250317  1
Show low-probability matches.